Gout is the crystallization of one measurable thing, uric acid, and it is among the most controllable forms of arthritis. An attack is a red, hot, agonizing joint that peaks in a day or two, and three treatments settle it fast: an anti-inflammatory, low-dose colchicine, or a short course of steroids. The lasting fix is a separate job. For someone whose attacks keep returning or whose joints are being damaged, a daily urate-lowering tablet such as allopurinol, taken for the long term and driven to a target below 6 mg/dL, dissolves the crystals and stops the attacks, which diet alone rarely does.
Diet still lowers the level: beer, spirits and sugary drinks raise uric acid, while losing excess weight, low-fat dairy, coffee, cherries and a DASH-style plate bring it down. The size of that effect is modest, so once attacks are frequent, diet works alongside the tablet. Rule out one thing early: a single hot joint can be a joint infection, and an infection needs care the same day.
Practice Ranking
Every practice we track for Gout, ranked by how well the evidence supports it for this condition. Strength describes the evidence, not our endorsement.
6 practices · 3 to start with
| # | Practice | Evidence | Type | Cost | Effort | Results In | Add to plan |
|---|---|---|---|---|---|---|---|
| 1 | Alcohol Each daily beer raised the risk of new gout about half again, so cutting beer and spirits lowers it; wine showed no link. | Strong | Self-Directed | Free | Moderate to Hard | Weeks to Months | |
| 2 | Whole Foods Two or more sugary soft drinks a day nearly doubled gout risk and most meat or seafood raised it 40 to 50%, while purine-rich vegetables did not, so the change to make is sugary drinks and heavy meat. | Strong | Self-Directed | $ to $$ | Moderate to Hard | Weeks to Months | |
| 3 | Sodium Reduction & DASH Diet The DASH pattern lowered uric acid 0.35 mg/dL on average, and 1.29 in those starting highest, and eating closest to it meant about 32% lower gout risk. | Moderate | Self-Directed | Free to $ | Moderate | Days to Weeks | |
| 4 | Caffeine Six or more coffees a day tracked with well under half the gout risk. | Moderate | Self-Directed | Free to $ | Easy | Days | |
| 5 | Weight Loss Lowers urate and flare risk in people carrying extra weight. | Moderate | Self-Directed | Free to $$$ | Moderate to Hard | Weeks to Months | |
| 6 | Vitamin C The highest vitamin C intake tracked with about half the gout risk, and supplements lowered uric acid about 0.35 mg/dL, a modest add-on rather than a substitute for urate-lowering therapy in established gout. | Moderate | Supplement | $ | Easy | Days | |
Default order puts the best-supported practices first, with self-directed care ahead of clinical options. Click any row to open the practice.
What It Is
Gout is a disease of crystals. It begins with uric acid, a waste product the body makes when it breaks down purines, the building blocks found in the body's own cells and in food. Uric acid dissolves in the blood only up to about 6.8 mg/dL at body temperature. Above that line, held there long enough, it comes out of solution as sharp needle-shaped urate crystals that settle in a joint, most often the base of the big toe, where it is coolest.
An attack, or flare, is the joint reacting to those crystals: sudden red, hot, swollen, unbearable pain that comes on overnight, peaks in a day or two, and settles within a week or two even without treatment. Because it settles on its own, many people get through a first flare without ever looking for the cause, and gout keeps returning.
The serum urate level is the number underneath all of it. When it stays high enough for long enough, crystals keep forming and attacks keep returning. Bring the level down and hold it down, and the crystals dissolve and the attacks stop. Gout usually moves through stages:
- A first flare is a single attack that then quietens.
- Recurrent gout is attacks that keep returning, in the same joint or new ones, with normal-feeling stretches between them. Each flare signals that the urate has been sitting high enough to seed more crystals.
- Chronic tophaceous gout is years of high urate leaving chalky deposits, called tophi, in and around joints, under the skin, and in the ear, which can slowly damage the joint.
- A high level with no attack shows up on a blood test in someone who has never had a flare. Most people at this stage never develop gout, so it is usually a prompt to look at the drinks and the weight before reaching for medication.
Gout rarely occurs alone. High uric acid clusters with excess weight, high blood pressure, type 2 diabetes, high cholesterol and chronic kidney disease, together often called metabolic syndrome, and each one both raises urate and is raised by the same habits. So the levers that lower gout risk, chiefly losing excess weight and a DASH-style plate, are the same ones that protect the heart and the kidneys. Managing gout well means treating the weight, blood pressure and blood sugar alongside the joint.
What Helps
Gout is two separate jobs, and the treatments for one do little for the other. The first is settling an attack that is happening now. The second is lowering the uric acid level over the long run so attacks stop happening at all. The diet and lifestyle levers sit alongside both, lowering the level modestly and working with the medical treatment once attacks are frequent.
Settling an attack that is happening now
An acute flare is treated to calm the inflammation, and three options work about equally well:
- an anti-inflammatory painkiller such as naproxen
- low-dose colchicine
- a short course of an oral steroid such as prednisolone
The choice among them turns on your other conditions. Anti-inflammatories are avoided in kidney disease and stomach ulcers. Colchicine is reduced or avoided in kidney impairment and with certain interacting drugs. A short steroid course suits people who cannot take the other two.
Starting early matters most. Low-dose colchicine (1.8 mg over the first hour) started within the first 12 hours of a flare eased pain in about 38% of people against 16% on a dummy pill, and did that as well as the old high dose while causing far less diarrhea, 23% against 77%. Started late, any of these works less well, so agree a plan with your prescriber ahead of the next attack.
A single hot, swollen joint can be a joint infection, which can destroy the joint within days and needs same-day care.
The lasting fix: lowering urate to target
Settling a flare does nothing to the crystals still in the joint or the level that keeps making them. The treatment that stops gout returning is a daily urate-lowering tablet taken for the long term, and for recurrent or tophaceous gout it is the most effective step on this page. Allopurinol is the usual first choice. In the one trial against a dummy pill it brought 96% of people to their target uric acid level against none on placebo, and holding the level down is what dissolves the existing crystals over months and prevents new attacks. Guidelines set the target below 6 mg/dL for most people, and below 5 mg/dL when there are tophi to dissolve, because both sit under the roughly 6.8 mg/dL at which urate stays in solution.
Two steps decide whether it works:
- Start low and raise slowly to reach the target, with an anti-inflammatory or colchicine alongside for the first months, because attacks can briefly increase as long-settled crystals begin to mobilize. People not warned of this often stop the tablet at the first flare and conclude it failed, when the early flare is the treatment starting to work.
- Take it for the long term, usually for life, because the level climbs straight back when it stops.
Febuxostat is an alternative when allopurinol is not tolerated. One large trial found more cardiovascular and overall deaths on febuxostat than on allopurinol, though a later trial did not repeat that signal, which is part of why allopurinol is preferred first.
The diet and drink levers
Diet is a lever, and the right place to start for a first flare, for a high level without symptoms, and as the base under everything else. The strongest levers are about what you drink. Each lowers the uric acid level modestly and reduces risk, and once attacks are frequent it works best as the base under the tablet.
What you drink moves the level most:
- Beer and spirits. Each daily beer raised the risk of developing gout by about half, and spirits by less, while wine in moderation showed no link at all in the same large study.
- Sugary and high-fructose drinks. Two or more sugary soft drinks a day nearly doubled the risk, and diet drinks carried no such link.
- Coffee. Six or more cups a day tracked with well under half the risk of drinking none, and the effect showed up partly with decaf, which argues it is not caffeine alone.
- Low-fat dairy. Skim milk and yogurt are linked to about 44% lower risk and appear to help the kidneys pass urate.
- A DASH-style plate. Heavier on vegetables, fruit, whole grains and low-fat dairy and lighter on red meat and sugar, it lowered the level in a feeding trial and tracked with about 32% lower gout risk in a long cohort.
- Losing excess weight. This sits underneath the rest, worth roughly 1 to 3 mg/dL off the level after a major loss and fewer attacks over time, though it is the hardest lever to hold.
- Cherries and vitamin C. The gentle helpers, each linked to a small benefit.
- Water. It helps the kidneys clear urate and lowers the risk of uric-acid kidney stones.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Gout
Each daily beer raised new-gout risk about half again (RR 1.49); wine showed no link
Each daily beer raised the risk of developing gout by about half and spirits by less, while wine showed no link; heavy drinkers had roughly two and a half times the risk of non-drinkers.
Each daily 12-ounce serving of beer carried a multivariate relative risk of new gout of 1.49 (95% CI 1.32 to 1.70), and each daily serving of spirits 1.15 (1.04 to 1.28). Wine showed no association (RR 1.04 per daily glass, 0.88 to 1.22). Compared with abstainers, men drinking 50 g or more of alcohol a day had 2.53 times the risk (1.73 to 3.70). Measured in: 47,150 men in the Health Professionals Follow-up Study with no history of gout at baseline, followed 12 years, with 730 incident cases. What could explain it instead: Heavy drinkers tend to weigh more, eat more meat, and differ in overall health behavior, all of which independently raise gout risk; residual confounding could inflate the alcohol association even after adjustment.. This is an observational cohort, so it shows association, not proof of cause. Heavier drinkers differ from abstainers in diet, weight and other habits; the analysis adjusted for many of these but cannot remove them all. The type-specific pattern (beer worst, wine neutral) is consistent with beer's purine content plus alcohol.
Who this may not transfer to:A male-only cohort of health professionals. Women develop gout later and less often, largely after menopause; the direction of the alcohol link is thought to hold but was not measured here.
The study · 1
Choi et al., alcohol intake and risk of incident gout in men: a prospective study · Lancet 2004;363(9417):1277-81
Two or more sugary soft drinks a day nearly doubled gout risk (RR 1.85)
Men who drank two or more sugary soft drinks a day had nearly double the risk of developing gout, while diet drinks carried no extra risk.
Men drinking two or more sugar-sweetened soft drinks a day had 1.85 times the risk of new gout against less than one a month (95% CI 1.08 to 3.16). The highest fifth of fructose intake had about twice the risk of the lowest (RR 2.02, 1.49 to 2.75). Diet soft drinks showed no association. Measured in: 46,393 men in the Health Professionals Follow-up Study with no baseline gout, followed 12 years, with 755 incident cases. What could explain it instead: Higher sugary-drink intake tracks with higher body weight and total calorie intake, both of which raise gout risk on their own; adjustment reduces but does not eliminate this.. An observational cohort showing association rather than cause. That diet drinks carried no risk while sugary ones did points at fructose specifically, which raises urate by speeding purine breakdown, but people who drink many sugary drinks also differ in weight and diet.
Who this may not transfer to:Male-only cohort. A companion analysis in women found a similar link between sugary drinks and gout, so the direction appears to transfer, but the numbers here are the men's.
The study · 1
Choi et al., soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study · BMJ 2008;336(7639):309-12
Most meat or seafood raised gout risk 40 to 50%; purine-rich vegetables did not
Eating the most meat or seafood raised the risk of developing gout by about 40 to 50%, while purine-rich vegetables like beans and spinach carried no risk at all.
Men in the highest fifth of meat intake had 1.41 times the gout risk of the lowest (95% CI 1.07 to 1.86), and the highest fifth of seafood 1.51 (1.17 to 1.95). Purine-rich vegetables showed no association (RR 0.96), and total protein was not linked to risk. Measured in: 47,150 men in the Health Professionals Follow-up Study, 12 years, 730 incident cases. What could explain it instead: High meat and seafood eaters differ in weight and overall diet; adjustment addresses much but not all of this.. Observational, so association not cause. The important finding is what is absent: the purine-rich plants that old gout diets banned (beans, peas, mushrooms, spinach) carried no risk, which overturns a long-standing piece of advice.
Who this may not transfer to:Male-only cohort. The plant-purine finding (no risk) is mechanistically general and widely applied to women too, but was measured in men.
The study · 1
Choi et al., purine-rich foods, dairy and protein intake, and the risk of gout in men · N Engl J Med 2004;350(11):1093-103
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Allopurinol brought 96% to target urate, against none on placebo
In the one trial against a dummy pill, allopurinol brought 96% of people to their target uric-acid level against none on placebo, which is how ongoing treatment dissolves crystals and prevents future attacks.
In the one placebo-controlled trial, allopurinol brought 96% of people (25 of 26) to the target serum urate against 0% (0 of 25) on placebo, a risk ratio of 49.11 (95% CI 3.15 to 765.58); the very wide interval reflects the small trial. The full Cochrane review covered 11 trials and 4,531 participants, but most compared allopurinol with other urate-lowering drugs rather than placebo, and against febuxostat allopurinol reached target less often (RR 0.56, 95% CI 0.48 to 0.65). Short-term evidence on preventing acute attacks was limited, in part because flares can rise when urate-lowering first starts. Measured in: The placebo comparison rested on 1 trial with 57 participants; the wider Cochrane review pooled 11 randomized trials and 4,531 participants with chronic gout, mostly comparing allopurinol with other active urate-lowering drugs. The placebo comparison is small (57 people), so the effect is certain in direction but wide in range. What is consistent across the evidence is that allopurinol reliably lowers urate to target, the mechanism by which sustained treatment dissolves crystals and prevents attacks. Short-term trials capture the early period when flares can temporarily increase, so they understate the longer-term benefit that comes once the level is held down with flare cover during the first months.
Who this may not transfer to:Both sexes across the trials; allopurinol dosing is individualised and titrated to the target urate level rather than fixed.
The study · 1
Seth et al., allopurinol for chronic gout · Cochrane Database Syst Rev 2014;(10):CD006077
Early low-dose colchicine eased pain in 38% versus 16% on placebo, with far less diarrhea
Started early in a flare, a low dose of colchicine eased pain in about 38% of people against 16% on a dummy pill, and worked as well as the old high dose with far less diarrhea.
For an early acute flare, low-dose colchicine (1.8 mg over one hour) produced at least a 50% reduction in pain at 24 hours in 38% of people, against 16% on placebo. It matched high-dose colchicine (4.8 mg over six hours) for pain relief while causing far less diarrhea (23% versus 77%). Measured in: 184 adults with an acute gout flare of no more than 12 hours' duration, randomized to low-dose colchicine, high-dose colchicine, or placebo. This tests colchicine started very early in a flare, within 12 hours, which is when it works best; started late it is less effective. The low, better-tolerated dose worked as well as the old high dose, which was often abandoned because of its gut side effects.
Who this may not transfer to:Both sexes; colchicine dosing is reduced in kidney impairment and with certain interacting drugs, so the dose is not universal.
The study · 1
Terkeltaub et al., high versus low dosing of oral colchicine for early acute gout flare (AGREE): a multicenter, randomized, double-blind, placebo-controlled trial · Arthritis Rheum 2010;62(4):1060-8
Major weight loss lowered uric acid by roughly 1 to 3 mg/dL and cut attacks over time
Losing weight lowered uric acid in the blood, by roughly 1 to 3 points after major weight loss, and led to fewer gout attacks over time.
Across 10 longitudinal studies, weight loss was associated with lower serum urate and, over time, reduced frequency of gout attacks. Reductions in serum urate after substantial (mostly bariatric) weight loss ranged from roughly 1 to 3 mg/dL, and several studies reported fewer flares at follow-up. The authors graded the overall certainty as low to moderate. Measured in: Overweight and obese adults with gout or hyperuricemia across 10 longitudinal studies, most non-randomized and several involving bariatric surgery. The evidence is low certainty: mostly non-randomized, with varied methods and no pooled effect estimate. Attacks can rise transiently in the first weeks after rapid weight loss or bariatric surgery, as mobilized urate crystallizes, before frequency falls, so the short-term and long-term pictures differ.
Who this may not transfer to:A synthesis of heterogeneous studies rather than a single cohort; the magnitude depends heavily on how much weight is lost and how (bariatric surgery drove the largest urate falls).
The study · 1
Nielsen et al., weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies · Ann Rheum Dis 2017;76(11):1870-1882
The most low-fat dairy meant about 44% lower gout risk
Men who ate the most low-fat dairy, such as skim milk and yogurt, had about 44% lower risk of developing gout.
Men in the highest fifth of dairy intake had 0.56 times the gout risk of the lowest (95% CI 0.42 to 0.74), roughly a 44% lower risk. The inverse link was driven by low-fat dairy such as skim milk and yogurt rather than high-fat dairy. Measured in: 47,150 men in the Health Professionals Follow-up Study, 12 years, 730 incident cases. What could explain it instead: Higher low-fat dairy intake correlates with a generally health-conscious diet and lower body weight, which independently lower gout risk.. Observational. Milk proteins (casein and lactalbumin) appear to increase urinary excretion of urate, which gives the association a plausible mechanism, but people who eat more low-fat dairy also tend to have healthier diets overall.
Who this may not transfer to:Male-only cohort; the dairy mechanism (urate excretion) is not sex-specific but the figure is the men's.
The study · 1
Choi et al., purine-rich foods, dairy and protein intake, and the risk of gout in men · N Engl J Med 2004;350(11):1093-103
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Six or more coffees a day meant well under half the gout risk (RR 0.41)
Men who drank six or more cups of coffee a day had well under half the risk of developing gout; decaf helped a little and tea not at all.
Men drinking six or more cups of coffee a day had 0.41 times the risk of new gout against none (95% CI 0.19 to 0.88), and four to five cups 0.60 (0.41 to 0.87). Decaffeinated coffee showed a weaker inverse link (RR 0.73 for four or more cups), and tea showed none, suggesting the effect is not caffeine alone. Measured in: 45,869 men in the Health Professionals Follow-up Study with no baseline gout, 12 years, 757 incident cases. What could explain it instead: Coffee intake correlates with smoking, alcohol and dietary patterns; the analysis adjusted for these, but residual confounding remains possible in any observational diet study.. Observational. That decaf showed a partial effect and tea none argues against reverse causation and against caffeine being the sole cause, but heavy coffee drinkers differ in other ways that adjustment cannot fully capture.
Who this may not transfer to:Male-only cohort. A separate analysis in women found a similar inverse link, so the direction appears to transfer.
The study · 1
Choi et al., coffee consumption and risk of incident gout in men: a prospective study · Arthritis Rheum 2007;56(6):2049-55
The highest vitamin C intake meant about half the gout risk, 17% lower per 500 mg
Men with the highest vitamin C intake had about half the risk of developing gout, with risk dropping roughly 17% for each extra 500 mg a day.
Men whose total vitamin C intake was 1,500 mg a day or more had 0.55 times the risk of new gout against less than 250 mg (95% CI 0.38 to 0.80). Risk fell by roughly 17% for each additional 500 mg a day of intake. Measured in: 46,994 men in the Health Professionals Follow-up Study with no baseline gout, followed 20 years, with 1,317 incident cases. What could explain it instead: People taking high-dose vitamin C supplements are more health-conscious on average (diet, weight, activity), which independently lowers gout risk.. Observational, showing association not cause. Vitamin C increases urinary excretion of urate, which supports the link, but the highest-intake group largely reached that level through supplements and tends to differ in health behavior.
Who this may not transfer to:Male-only cohort; the urate-excretion mechanism is not sex-specific but the figure is the men's.
The study · 1
Choi et al., vitamin C intake and the risk of gout in men: a prospective study · Arch Intern Med 2009;169(5):502-7
Vitamin C supplements lowered uric acid about 0.35 mg/dL
Vitamin C supplements lowered uric acid in the blood by a small amount, about 0.35 points, far less than a gout medicine achieves.
Pooling 13 randomized trials, vitamin C supplementation lowered serum uric acid by 0.35 mg/dL (95% CI -0.66 to -0.03) against control. The median dose was 500 mg a day and the median trial length 30 days. Measured in: 556 participants across 13 randomized controlled trials, mostly in people without gout. The drop is small, about 0.35 mg/dL, far less than a urate-lowering drug delivers, and the trials were short and mostly in people without gout. Lowering the average level is not the same as preventing flares, and a later trial in gout patients found little effect on urate, so vitamin C is best read as a minor helper rather than a treatment.
Who this may not transfer to:Both sexes across the trials, but most participants did not have gout, so the finding is about the urate level in general rather than about flare prevention in people who already have gout.
The study · 1
Juraschek et al., effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials · Arthritis Care Res (Hoboken) 2011;63(9):1295-306
DASH lowered uric acid 0.35 mg/dL on average, 1.29 in those starting highest
The DASH eating pattern lowered uric acid by a small amount on average, but by a much larger amount in people who started with the highest levels.
In a controlled feeding trial, the DASH diet lowered serum uric acid by 0.35 mg/dL against a typical control diet (95% CI -0.65 to -0.05). Among participants who started with the highest urate (7 mg/dL or more), it fell by 1.29 mg/dL. Higher sodium intake had the opposite, smaller effect, slightly lowering urate. Measured in: 103 adults with above-optimal blood pressure in a secondary analysis of the DASH-Sodium controlled feeding trial, fed each diet under supervision. This is a secondary analysis of a trial designed for blood pressure, in people with raised blood pressure rather than gout, and all food was supplied under controlled conditions, which is more than a person achieves at home. The larger fall in those starting highest is the more clinically relevant number.
Who this may not transfer to:Both sexes, but selected for raised blood pressure rather than gout; the urate effect is expected to transfer to people with gout, especially those starting with a high level.
The study · 1
Juraschek et al., effects of the Dietary Approaches to Stop Hypertension (DASH) diet and sodium intake on serum uric acid · Arthritis Rheumatol 2016;68(12):3002-3009
Eating closest to DASH meant about 32% lower gout risk
Men whose eating most resembled the DASH pattern had about a third lower risk of developing gout, while a more Western diet raised it.
Men whose eating most closely matched a DASH pattern had 0.68 times the risk of new gout against those who matched it least (95% CI 0.57 to 0.80), about a 32% lower risk. Those eating a more Western pattern (red and processed meat, sugar, refined grains) had 1.42 times the risk (1.16 to 1.74). Measured in: 44,444 men in the Health Professionals Follow-up Study with no baseline gout, followed 26 years, with 1,731 incident cases. What could explain it instead: A high DASH score tracks with lower body weight, more activity and less alcohol, each of which independently lowers gout risk; adjustment reduces but does not remove this overlap.. Observational, showing association not cause, though it aligns with the feeding trial that measured urate directly under controlled conditions. Diet-pattern scores capture broad eating habits that travel with weight, activity and other behaviors.
Who this may not transfer to:Male-only cohort; the pattern is consistent with the mixed-sex DASH feeding trial, which supports transfer to women.
The study · 1
Rai et al., the DASH diet, Western diet, and risk of gout in men: prospective cohort study · BMJ 2017;357:j1794
Eating cherries was linked to about 35% lower odds of a gout attack
Eating cherries over a couple of days was linked to about 35% lower odds of a gout attack in that window, and lower still when combined with allopurinol.
Eating cherries over a two-day period was associated with 0.65 times the odds of a gout attack in that window against no intake (95% CI 0.50 to 0.85), roughly 35% lower odds. Cherries taken together with allopurinol were associated with 0.25 times the odds. Measured in: 633 people with gout recruited online, contributing 1,247 attacks over one year, each comparing exposure in the two days before an attack against their own attack-free periods. What could explain it instead: People may eat cherries precisely when they sense an attack coming, or change other habits at the same time, either of which could bias the within-person comparison.. A case-crossover design compares each person to themselves, which removes stable differences between people but cannot rule out that something else changed alongside cherry intake in those two days. Diet was self-reported by an online cohort, and the design cannot establish cause. The effect is modest and unconfirmed by a randomized trial.
Who this may not transfer to:Both sexes, self-selected online cohort with established gout; generalisability to a first-time or milder presentation is uncertain.
The study · 1
Zhang et al., cherry consumption and decreased risk of recurrent gout attacks · Arthritis Rheum 2012;64(12):4004-11
An enriched skim-milk powder lowered gout-flare frequency more than a dummy powder
A specially enriched skim-milk powder reduced how often gout flares happened, more than a dummy powder, though all groups improved somewhat.
Over three months, self-reported gout flares fell in all three groups. The largest fall was in the group taking skim milk powder enriched with glycomacropeptide and a milk-fat extract (G600), which had a significantly greater reduction in flare frequency than the lactose-powder control. Measured in: 120 people with recurrent gout in a three-arm, three-month proof-of-concept randomized trial comparing enriched skim milk powder, standard skim milk powder, and a lactose control powder. A small, short, proof-of-concept trial with flares self-reported, and a placebo response is visible in that all three groups improved. It tests a specific enriched milk product rather than ordinary dairy, so it supports the dairy signal without proving a plain-milk effect on flares.
Who this may not transfer to:Both sexes with established recurrent gout; the product tested is not ordinary supermarket milk, so read it as support for the dairy direction rather than a dosing instruction.
The study · 1
Dalbeth et al., effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial · Ann Rheum Dis 2012;71(6):929-34
What Diet Alone Can and Cannot Do
The diet levers are worth doing, and each has a mechanism behind it. Their effect on the uric-acid level is small. The DASH pattern lowered uric acid by about 0.35 mg/dL on average in a controlled feeding trial, reaching 1.29 mg/dL in the people who started highest, and vitamin C supplements lowered it by a similar 0.35 mg/dL. Even a major weight loss moves it 1 to 3 mg/dL. A daily urate-lowering tablet brings almost everyone to a target below 6 mg/dL.
So for a first flare, a raised level with no symptoms, or general risk reduction, diet is a sensible and sufficient first move. For recurrent attacks or tophi, diet helps but rarely gets the level low enough on its own, and using it as a substitute for the tablet at that stage is the most common way people stay stuck in a cycle of flares. Lowering the average level is also not the same as preventing a flare: vitamin C lowers the number a little but has not been shown to cut the flares themselves, so it works on top of the bigger levers.
One old piece of diet advice is wrong and can be dropped. Beans, lentils, peas, mushrooms and spinach were banned from gout diets for generations because they contain purines, but in the large cohorts these purine-rich vegetables carried no increased risk at all. The purines that matter come from meat and seafood, which did raise risk, and from alcohol and fructose. Total protein was not linked to gout either. The plant foods once forbidden are fine, and a purine-free crash diet is neither necessary nor effective.
What To Do First
None of this needs a prescription, and it works alongside whatever your prescriber has you on. Start with the drinks, since they move the level the most for the least effort, and take a rising level or returning attacks as the signal to add the tablet.
These are the biggest daily levers. Each daily beer raised gout risk by about half and two or more sugary soft drinks a day nearly doubled it, while wine in moderation and diet drinks showed no link. Coffee and water are the drinks to keep.
Skim milk and yogurt track with about 44% lower risk and help the kidneys pass urate. Build meals on vegetables, fruit, whole grains and low-fat dairy with less red meat and sugar, the pattern linked to about 32% lower gout risk.
Beans, lentils, mushrooms and spinach carried no gout risk in the large cohorts, so the old ban on them was wrong. The purines that matter come from meat, seafood, alcohol and sugary drinks.
This is the lever underneath the rest, worth roughly 1 to 3 mg/dL off the level after a major loss and fewer attacks over time. Go steady, because attacks can briefly rise in the weeks right after rapid loss before they fall.
You can order a serum uric-acid test yourself through direct-to-consumer testing and re-check it as you change things. Below about 6 mg/dL is the target that keeps crystals from forming.
Returning attacks, tophi you can feel, or a level that stays high are the point where a daily urate-lowering tablet is usually worth it. That decision, and the flare cover for the first months, is timed with your prescriber.
Go Deeper
- Weight and metabolic health: the lever underneath gout, and why the same habits protect the heart and kidneys.
- The DASH diet and cutting sodium: the eating pattern that lowered uric acid in a feeding trial, plate by plate.
- Alcohol: where beer and spirits sit against wine, and how intake tracks with gout and wider health.
- Coffee and caffeine: the drink linked to lower gout risk.
- Vitamin C: the gentle helper that lowers the level a little.
- Kidney stones: the uric-acid stones that share a cause with gout, and how hydration helps both.
The Chinese Medicine View
The Chinese Medicine View
Chinese medicine reads gout as a form of Bi syndrome (痹证), an obstruction of qi and blood in the joints, and names the burning-hot swollen version Damp-Heat pooling in the channels. The classical cause matches the modern one closely: the old texts blamed rich, fatty, sweet food and alcohol for breeding damp-heat that settles in the joints, almost the same list the modern cohorts later confirmed. Read the patterns below as a lens on how a person presents. They do not replace a uric-acid level. Two situations call for tonifying and moving alongside clearing heat: many long-standing patients show an underlying Spleen and Kidney deficiency that fails to transform fluids, and the chalky tophi of chronic gout are read as phlegm-damp congealed with blood stasis. The cooling, damp-draining herbs are the wrong direction for someone cold, pale, loose in the bowels and depleted.
The acute flare: a joint that is red, hot, swollen and severely painful, often the big toe or foot, worse for heat and pressure, with a red tongue and a greasy yellow coat. The direction is to clear heat, drain damp and unblock the channel.
Chronic gout with hard lumps (tophi), a dusky or fixed ache, and deformity building over years. The direction is to transform phlegm, move blood and dissolve the accumulation.
The underlying terrain in many recurrent cases: fatigue, poor digestion, loose stools, low back and knee weakness, a pale swollen tongue. The direction is to strengthen the Spleen and support the Kidneys so damp is transformed rather than left to pool.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Do not stop your urate-lowering tablet during a flare
If you already take allopurinol or another urate-lowering drug, keep taking it through an attack. Stopping and restarting swings the uric-acid level, and those swings can set off more flares. Treat the flare with the anti-inflammatory, colchicine or steroid you were given, and leave the daily tablet running. Starting a urate-lowering tablet for the first time is timed with your prescriber, with flare cover for the first months.
Allopurinol hypersensitivity and the HLA-B*5801 gene
Allopurinol rarely triggers a severe hypersensitivity reaction that starts as a spreading rash and can progress to blistering and peeling skin. The risk is strongly linked to a gene variant, HLA-B*5801, which is far more common in people of Han Chinese, Korean and Thai ancestry, and testing for it before starting allopurinol is recommended for those higher-risk groups. Starting at a low dose and raising it slowly also lowers the risk. A widespread rash, blistering, facial swelling or peeling skin after starting the drug means stopping it and seeking care the same day.
Match the acute treatment to your kidneys and other drugs
The three flare treatments are not interchangeable for everyone. Anti-inflammatory painkillers such as ibuprofen and naproxen are avoided in kidney disease and with stomach ulcers. Colchicine is reduced or avoided in kidney impairment and with certain interacting drugs, since it can build up to toxic levels. A short course of an oral steroid is often the safer choice when the other two do not fit. This is a question of which one suits you, agreed with your prescriber before an attack where possible.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
When to See Someone
Most of managing gout is steady and in your own hands. A few situations are different, and one rule sits above the rest: a single hot, swollen, agonizing joint can be a joint infection, and an infection can destroy a joint within days. These are the signs to get seen about:
- A hot, swollen, very painful joint together with fever, chills, or feeling generally unwell, which can mean a joint infection (septic arthritis) that needs to be drained and treated within days to save the joint. Fever or a first-ever attack in an unusual joint tips a single hot joint toward infection(seek urgent care)
- A first-ever attack that involves several joints at once, or a large joint such as the knee or shoulder, or comes with a high fever, which is not the usual pattern and needs assessment(seek urgent care)
- A widespread rash, blistering, facial swelling or peeling skin after starting allopurinol or another urate-lowering drug, which can be a serious hypersensitivity reaction; stop the drug and seek care(seek urgent care)
- Severe one-sided flank or back pain, or blood in the urine, which can be a uric-acid kidney stone
- A gout attack that is not settling after several days of the treatment you were given, or that keeps returning within weeks
- Frequent attacks, tophi you can feel or see, or a uric-acid level that stays high, all of which are the point at which a daily urate-lowering tablet is usually worth discussing
- Known kidney disease, or a first attack under 40, both of which change which drugs are safe and are worth flagging before you start one
None of this is meant to alarm you. Gout is among the most controllable joint conditions there is: the diet and weight levers are largely in your hands, the medication works well when it is needed, and the main thing to rule out early is a joint infection. You can order your own uric-acid level through direct-to-consumer testing and track it as you change things, and take any decision about medication to the person who prescribes it.
Common Questions
What actually causes gout?
One thing: uric acid that stays high enough to crystallize. Uric acid dissolves in blood only up to about 6.8 mg/dL, and above that line, held long enough, it forms sharp urate crystals that settle in a joint and set off the red, hot, agonizing swelling of a flare. Rich food and alcohol matter because they raise the level. The level itself is the disease, so lowering it and keeping it down is what stops gout coming back.
Can I get rid of gout by changing my diet?
For a first flare or a raised level with no attacks, often yes, and diet is the right first move. For attacks that keep returning, diet helps but rarely gets the level low enough on its own. The diet levers are modest in size: the DASH pattern lowered uric acid by about 0.35 mg/dL on average in a feeding trial, and even a major weight loss moves it 1 to 3 mg/dL, while a daily allopurinol tablet brings almost everyone below the target. So diet is a useful adjunct, and once attacks are frequent it works best alongside the tablet.
Do I really have to avoid beans, spinach and mushrooms?
No. Purine-rich vegetables such as beans, lentils, mushrooms and spinach carried no increased gout risk at all in the large cohort of nearly 47,150 men, and total protein was not linked either. The purines that raise risk come from meat and seafood, and the biggest drivers are alcohol and fructose. The old ban on purine-rich plants was wrong, so keep them on the plate.
Do cherries or vitamin C actually work?
Both help a little. Eating cherries over a two-day window was linked to about 35% lower odds of a gout attack in that window in a study of 633 people, and lower still alongside allopurinol, though the design cannot prove cause. Vitamin C supplements lowered uric acid by about 0.35 mg/dL across 13 trials, a small drop that has not been shown to cut the flares themselves. Treat both as gentle helpers on top of the bigger levers.
Should I take allopurinol, and is it safe?
It is the most effective step for recurrent or tophaceous gout, where diet alone rarely reaches target. In the one trial against a dummy pill, allopurinol brought 96% of people to their target uric-acid level against none on placebo, which is how sustained treatment dissolves crystals and prevents attacks. It is started low, raised slowly to a target below 6 mg/dL, and taken long term with flare cover for the first months. The main safety point is a rare severe skin reaction linked to the HLA-B*5801 gene, which is more common in people of Han Chinese, Korean and Thai ancestry and is worth testing for before starting in those groups. Keep taking it through a flare.
How do I stop an attack right now?
Start treatment early, because all three options work best in the first hours. An anti-inflammatory such as naproxen, low-dose colchicine, or a short course of an oral steroid each settle a flare about equally well, and which suits you depends on your kidneys and other drugs. Started within 12 hours, low-dose colchicine eased pain in about 38% of people against 16% on a dummy pill, and the low dose worked as well as the old high dose with far less diarrhea. Agreeing a plan with your prescriber before the next attack lets you act at the first sign.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 14 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.